Pradeep Rebala
Overview
Explore the profile of Pradeep Rebala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Refaat M, Modak S, Harivelam C, Ullah S, Ferrar K, Pandya S, et al.
Clin Nutr ESPEN
. 2024 Aug;
63:845-855.
PMID: 39178986
Background: Enhancing a patient's functional capacity to withstand the surgical stress by means of multimodal (combined exercise, nutrition and psychological interventions) prehabilitation may potentially lead to improved outcomes in pancreatic...
2.
Nabi Z, Chaithanya M, Inavolu P, Ramchandani M, Reddy P, Sayyed M, et al.
Indian J Gastroenterol
. 2024 Aug;
43(5):1012-1020.
PMID: 39090330
Background: Endoscopic sub-mucosal dissection (ESD) is an established endoscopic modality for the management of colorectal polyps. However, there are no studies regarding the outcomes of ESD from India. In this...
3.
Ramaswamy A, Chaudhari V, Srinivas S, Bhargava P, Kannan S, Agarwal A, et al.
HPB (Oxford)
. 2024 Jul;
26(10):1261-1269.
PMID: 39019675
Background: The role of adjuvant therapy in resected periampullary adenocarcinomas is equivocal due to contrasting data and limited prospective trials. Methods: The Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP),...
4.
Kant K, Ahmed Z, Dama R, Karunakaran M, Arora P, Rebala P, et al.
Ann Hepatobiliary Pancreat Surg
. 2024 Apr;
28(3):350-357.
PMID: 38679455
Backgrounds/aims: This trial evaluated whether anti-inflammatory agents hydrocortisone (H) and indomethacin (I) could reduce major complications after pancreatoduodenectomy (PD). Methods: Between June 2018 and June 2020, 105 patients undergoing PD...
5.
Pal P, Rebala P, Nabi Z, Pooja K, Gupta R, Rao G, et al.
Indian J Gastroenterol
. 2024 Apr;
PMID: 38557943
No abstract available.
6.
Shasheendra Y, Ahmed Z, Shetty M, Hazarathaiah N, Rebala P, Rao G
Cureus
. 2024 Mar;
16(1):e53257.
PMID: 38435944
Background In this study, we aimed to determine the association between postoperative hyperamylasemia (POH) and clinically relevant postoperative pancreatic fistula (CR-POPF) after pancreatoduodenectomy (PD). Methodology A prospective observational study of...
7.
Ahmed Z, Patil S, Sekaran A, Rebala P, Rao G
Turk J Surg
. 2023 Dec;
39(3):190-196.
PMID: 38058374
Objectives: Indocyanine green (ICG) dye guided near infrared fluorescence (NIR) imaging is a promising tool for mapping lymphatics. The aim of this study was to evaluate the role of ICG...
8.
Gopal P, Ahmed Z, Venkata Ravi Kant V, Rao G, Rebala P
Turk J Surg
. 2023 Nov;
39(2):107-114.
PMID: 38026919
Objectives: Methylation status of Septin9 (SEPT9) and vimentin (VIM) genes in circulating tumor DNA of colorectal cancer (CRC) patients is a promising bio-marker for the early detection of CRC. The...
9.
Vishnubhotla R, Avanthi S, Mitnala S, Guduru V, Rebala P, Patil S, et al.
Mol Carcinog
. 2023 Nov;
63(3):361-370.
PMID: 37983720
Colorectal cancer (CRC) is known to follow adenoma carcinoma sequence (ACS) in majority of the tumors and the driver variants and associated pathways are well delineated. However, most of the...
10.
Pal P, Gala J, Rebala P, Banerjee R, Ramchandani M, Nabi Z, et al.
J Gastroenterol Hepatol
. 2023 Oct;
39(2):353-359.
PMID: 37897304
Background And Aim: Resection for Crohn's disease (CD) related strictures is definitive but carries risk of morbidity, recurrence, and short bowel syndrome. On the contrary, the durability of endotherapy (ET)...